Piper Sandler's Rating on UnitedHealth#
Piper Sandler has reaffirmed an Overweight rating for UnitedHealth Group (NYSE: UNH), maintaining a price target of $399. Currently, the stock trades at $322.82, with a price-to-earnings (P/E) ratio of 24.36. This means investors are willing to pay $24.36 for every dollar of earnings, which indicates that the stock might be undervalued according to some analyses.
Adjustments Ahead of Earnings Report#
Ahead of UnitedHealth's upcoming earnings report, Piper Sandler has adjusted its estimates for Optum Health's operating income for the year 2026. The firm believes that nearly two-thirds of the adjusted earnings per share (EPS) for 2026 will be realized in the first half of the year, aligning closely with UnitedHealth’s own guidance.
Earnings Projections#
Piper Sandler projects an adjusted EPS of $17.79 for 2026, which is slightly above the company's guidance of over $17.75 and near the consensus forecast of $17.89. This estimate remains unchanged from previous projections, indicating confidence in the company’s financial performance.
Support for Rural Healthcare Providers#
In recent developments, UnitedHealthcare has announced plans to support rural healthcare providers by eliminating most prior authorization requirements and speeding up payments to around 1,500 rural hospitals by fall 2026. This initiative aims to enhance healthcare access and efficiency in rural areas and will affect all lines of business, including Medicare Advantage and Medicaid.
Analyst Sentiment#
Other analysts have also shown confidence in UnitedHealth. Bernstein SocGen Group has reiterated an Outperform rating, citing a positive outlook for Medicare Advantage. Morgan Stanley and RBC Capital have also maintained favorable ratings, highlighting UnitedHealth’s strong position ahead of its upcoming earnings report.